Metformin-associated lactic acidosis in an elderly diabetic patient without classical risk factors: a case report
Therapeutic Advances in Drug Safety
Published online on March 07, 2026
Abstract
Therapeutic Advances in Drug Safety, Volume 17, January-December 2026.
Metformin is a cornerstone medication and first-line therapy for type 2 diabetes mellitus (T2DM), with a well-established safety profile and widespread use over many years. Its most common adverse effects are gastrointestinal in nature. However, the drug ...
Metformin is a cornerstone medication and first-line therapy for type 2 diabetes mellitus (T2DM), with a well-established safety profile and widespread use over many years. Its most common adverse effects are gastrointestinal in nature. However, the drug ...